Continuous Interscalene Block Results in Superior Recovery Throughout the First Postoperative Week
Postoperative Pain, Adverse Effects
About this trial
This is an interventional supportive care trial for Postoperative Pain focused on measuring Single injection interscalene brachial plexus block, Continuous interscalene brachial plexus block, General anesthesia, Postoperative pain, Recovery profile
Eligibility Criteria
Inclusion Criteria:
American Society of Anesthesiologists (ASA) physical status I-III patients
≥ 18 years of age BMI ≤ 35 kg/m2 Scheduled for elective arthroscopic shoulder surgery
Exclusion Criteria:
Patients who were undertaken open shoulder procedures Patients with difficulty understanding the instructions for using the anesthetic infusion pump and/or pain scales Patients with contraindications to regional anesthesia (e.g., allergy to a local anesthetic (LA), local infection, coagulopathy) Patients with significant neurologic disorders of the upper extremity, psychiatric or cognitive disorders, history of substance abuse or chronic opioid use
Sites / Locations
- St Luke's Roosevelt Hospital Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
No Intervention
Single ISB (SISB) group
Continuous ISB (CISB) group
General anesthesia (GA) group
Patients in this group received single injection (SISB) interscalene brachial plexus block
Patients in this group received continuous (CISB) interscalene brachial plexus block
Patients in this group received general anesthesia (GA)